Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Ilaria Depetris"'
Autor:
Alessandro Parisi, Riccardo Giampieri, Alex Mammarella, Cristiano Felicetti, Lisa Salvatore, Maria Bensi, Maria Grazia Maratta, Antonia Strippoli, Roberto Filippi, Maria Antonietta Satolli, Angelica Petrillo, Bruno Daniele, Michele De Tursi, Pietro Di Marino, Guido Giordano, Matteo Landriscina, Pasquale Vitale, Ina Valeria Zurlo, Emanuela Dell’Aquila, Silverio Tomao, Ilaria Depetris, Francesca Romana Di Pietro, Federica Zoratto, Davide Ciardiello, Maria Vittoria Pensieri, Ornella Garrone, Barbara Galassi, Claudio Ferri, Rossana Berardi, Michele Ghidini
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
AimThe aim of the current study is to investigate the impact of primary compared to secondary chemotherapy-induced nausea and vomiting (CINV) prophylaxis with NK1 receptor antagonists (NK1-RA) in patients affected by gastrointestinal malignancies and
Externí odkaz:
https://doaj.org/article/a870c172dbe94deaa83affaa21374c17
Autor:
Giuseppe Nicolò Fanelli, Carlo Alberto Dal Pozzo, Ilaria Depetris, Marta Schirripa, Stefano Brignola, Paola Biason, Mariangela Balistreri, Luca Dal Santo, Sara Lonardi, Giada Munari, Fotios Loupakis, Matteo Fassan
Publikováno v:
Cancer Cell International, Vol 20, Iss 1, Pp 1-12 (2020)
Abstract Colorectal cancer (CRC) is a complex and molecularly heterogeneous disease representing one of the most frequent causes of cancer-related death worldwide. About 8–15% of CRCs harbor a mutation in BRAF gene, a proto-oncogene involved in cel
Externí odkaz:
https://doaj.org/article/7de1e6340d0542cfb9107c560ec468f4
Autor:
Fotios Loupakis, Giulia Maddalena, Ilaria Depetris, Sabina Murgioni, Francesca Bergamo, Angelo Paolo Dei Tos, Massimo Rugge, Giada Munari, Andrew Nguyen, Christopher Szeto, Vittorina Zagonel, Sara Lonardi, Matteo Fassan
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-7 (2019)
Abstract Background Analysis of deficiency in DNA mismatch repair (dMMR) is currently considered a standard molecular test in all patients with colorectal cancer (CRC) for its implications in screening, prognosis and prediction of benefit from immune
Externí odkaz:
https://doaj.org/article/42bd19ba238948ee815a95ee2bf81be2
Autor:
Stefano Granieri, Christian Cotsoglou, Alessandro Bonomi, Lisa Salvatore, Roberto Filippi, Olga Nigro, Fabio Gelsomino, Ina Valeria Zurlo, Ilaria Depetris, Riccardo Giampieri, Rossana Berardi, Cristina Morelli, Michele De Tursi, Michela Roberto, Elson Gjoni, Alessandro Germini, Nicola de Angelis, Riccardo Memeo, Antonio Facciorusso, Ornella Garrone, Daryl Ramai, Michele Ghidini, Alessandro Parisi
Publikováno v:
Cancers, Vol 14, Iss 22, p 5513 (2022)
Colorectal cancer (CRC) patients frequently develop liver metastases. Different treatment strategies are available according to the timing of appearance, the burden of metastatic disease, and the performance status of the patient. Systemic treatment
Externí odkaz:
https://doaj.org/article/7e15f4be8c82477988aae314ee10d263
Autor:
Alessandro Parisi, Alessio Cortellini, Olga Venditti, Roberto Filippi, Lisa Salvatore, Giampaolo Tortora, Michele Ghidini, Olga Nigro, Fabio Gelsomino, Ina Valeria Zurlo, Claudia Fulgenzi, Pasquale Lombardi, Susana Roselló Keränen, Ilaria Depetris, Riccardo Giampieri, Cristina Morelli, Pietro Di Marino, Francesca Romana Di Pietro, Nicoletta Zanaletti, Pasquale Vitale, Ingrid Garajova, Gian Paolo Spinelli, Federica Zoratto, Michela Roberto, Angelica Petrillo, Giacomo Aimar, Leonardo Patruno, Carla D’Orazio, Corrado Ficorella, Claudio Ferri, Giampiero Porzio
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundFew data regarding post-induction management following first-line anti-epidermal growth factor receptor (EGFR)-based doublet regimens in patients with left-sided RAS/BRAF wild-type metastatic colorectal cancer (mCRC) are available.MethodsTh
Externí odkaz:
https://doaj.org/article/a4d272875d3649eb80da124a1aebeef6
Autor:
Elisabetta Fenocchio, Federica Colombi, Maria Grazia Calella, Roberto Filippi, Ilaria Depetris, Giovanna Chilà, Pasquale Lombardi, Donatella Marino, Celeste Cagnazzo, Renato Ferraris, Marco Vaira, Massimo Aglietta, Francesco Leone
Publikováno v:
Cancers, Vol 11, Iss 3, p 369 (2019)
The survival rates of patients with metastatic colorectal cancer (mCRC) have improved in recent years. We analysed the survival of mCRC patients followed at a single institution over the last 17 years. We retrospectively collected data from 899 mCRC
Externí odkaz:
https://doaj.org/article/6ebcb974e60a4b6182b555936c5b83c2
Autor:
Joris van de Haar, Xuhui Ma, Salo N. Ooft, Pim W. van der Helm, Louisa R. Hoes, Sara Mainardi, David J. Pinato, Kristi Sun, Lisa Salvatore, Giampaolo Tortora, Ina Valeria Zurlo, Silvana Leo, Riccardo Giampieri, Rossana Berardi, Fabio Gelsomino, Valeria Merz, Federica Mazzuca, Lorenzo Antonuzzo, Gerardo Rosati, Chara Stavraka, Paul Ross, Maria Grazia Rodriquenz, Michele Pavarana, Carlo Messina, Timothy Iveson, Federica Zoratto, Anne Thomas, Elisabetta Fenocchio, Margherita Ratti, Ilaria Depetris, Massimiliano Cergnul, Cristina Morelli, Michela Libertini, Alessandro Parisi, Michele De Tursi, Nicoletta Zanaletti, Ornella Garrone, Janet Graham, Raffaella Longarini, Stefania Maria Gobba, Angelica Petrillo, Emiliano Tamburini, Nicla La Verde, Fausto Petrelli, Vincenzo Ricci, Lodewyk F. A. Wessels, Michele Ghidini, Alessio Cortellini, Emile E. Voest, Nicola Valeri
Publikováno v:
Nature Medicine
Genomics has greatly improved how patients with cancer are being treated; however, clinical-grade genomic biomarkers for chemotherapies are currently lacking. Using whole-genome analysis of 37 patients with metastatic colorectal cancer (mCRC) treated
Autor:
N. Zanaletti, Susana Roselló Keränen, Debora Ierinò, Riccardo Giampieri, Michele De Tursi, Fabio Gelsomino, Ingrid Garajová, Alessio Cortellini, P. Vitale, Pasquale Lombardi, Emanuela Dell'Aquila, Teresa Troiani, Silvana Leo, Andrea Spallanzani, Giampiero Porzio, Ilaria Depetris, Federica De Galitiis, Olga Venditti, Angelica Petrillo, Michela Roberto, Francesca Di Pietro, Corrado Ficorella, Olga Nigro, Michele Ghidini, Roberto Filippi, Giampaolo Tortora, Antonio Avallone, Katia Cannita, Nicola Tinari, Gian Paolo Spinelli, Cristina Morelli, Lisa Salvatore, Giacomo Aimar, Fulgenzi Claudia, Alessandro Parisi, M. Ribelli, Valeria Zurlo, Federica Zoratto, Carla D'Orazio
Publikováno v:
Clinical Colorectal Cancer
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
BACKGROUND: Doublets plus antiepidermal growth factor receptors monoclonal antibodies (EGFRi) are widely considered the preferable first-line regimen in patients with left-sided RAS/BRAF wild-type metastatic colorectal cancer (mCRC), resulting superi
Publikováno v:
Expert Opinion on Pharmacotherapy. 22:677-684
Introduction: Characteristic of some rare pediatric and adult malignancies, addiction to the NTRK oncogene family is also observed in a small fraction of common cancers. Inhibition of their protein products, the Trk kinases, proved a successful treat
Autor:
N. Zanaletti, Susana Roselló Keränen, Claudio Ferri, Fabio Gelsomino, Paolo Antonetti, P. Vitale, Riccardo Giampieri, Angelica Petrillo, Emanuela Dell'Aquila, Alessandro Parisi, Michele De Tursi, Alessio Cortellini, Corrado Ficorella, Cristina Morelli, Ilaria Depetris, Giampiero Porzio, Ina Valeria Zurlo, Michela Roberto, Giacomo Aimar, Francesca Di Pietro, Federica Zoratto, Maria Concetta Fargnoli, Lisa Salvatore, Olga Nigro, Michele Ghidini, Gian Paolo Spinelli, Maria Vittoria Pensieri, Ingrid Garajová, Pasquale Lombardi, Roberto Filippi
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in CancerReferences. 30(3)
Skin toxicity in patients affected by metastatic colorectal cancer (mCRC) treated with epidermal growth factor receptor (EGFR) inhibitors is well known. However, ad hoc ESMO guidelines have only recently been published. To describe the management (pr